Click for next page ( 222


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 221
D Biographical Notes on Committee Members STUART H. ALTMAN, dean of the Helter Graduate School for Social Policy, Brandeis University, and Sol C. Chaikin Professor of National Health Policy, is in his second term as chairman of the congressionally legislated Prospective Payment Assessment Commission, which oversees the Medicare hospital payment system. Between 1971 and 1976, Dean Altman was deputy assistant secretary for planning and evaluation/health in the Department of Health, Education, and Welfare. As deputy assistant secretary, he was one of the principal contributors to the development and advancement of the administration's national health insurance pro- posal. From 1973 to 1974, he served as deputy director for health of the President's Cost-of-Living Council and was responsible for developing the council's program on health care cost containment. Dean Altman has testified before various congressional committees on the problems of rising health care costs and the need to mandate a minimum benefits package for all full-time workers. He holds a Ph.D. in economics from the University of California, Los Angeles, and has taught at Brown Univer- sity and the University of California, Berkeley. DAVID BALTIMORE is director of the Whitehead Institute for Bio- medical Research and professor of biology at the Massachusetts Institute of Technology. From 1974 until 1982, when he was named director of the institute, he was with the Center for Cancer Research of the Massachu- setts Institute of Technology. He has taught in the Department of Biology at the Massachusetts Institute of Technology since being appointed to the 221

OCR for page 221
222 APPENDIX D faculty in 1968. In 1975 he received the Nobel Prize, together with Howard Temin and Renato Dulbecco, for the discovery of reverse transcriptase retroviruses. That same year he was an organizer of the Asilomar Conference in California, which focused attention on the development of genetic engineering, and he was later a member of the National Institutes of Health Recombinant DNA Advisory Committee. His present research focuses on molecular immunology, virology, AIDS, and cancer. Dr. Baltimore received his B.A. degree in chemistry from Swarthmore College and his Ph.D. in biology from Rockefeller Univer- sity. THEODORE COOPER is chairman of the board and chief executive officer of The Upjohn Company, Kalamazoo, Michigan. Prior to joining Upjohn in 1980, Dr. Cooper was dean of the Cornell University Medical College. He was appointed to that position in 1977. From 1975 until 1977, he served as assistant secretary for health in the Department of Health, Education, and Welfare. Dr. Cooper has also directed the Heart and Lung Institute of the National Institutes of Health and has held academic appointments at St. Louis University, the University of New Mexico, Cornell University Medical College, and Rockefeller University. He is the author or coauthor of more than 150 scientific papers and is a member of the American College of Cardiology, the American Physiological Society, the American Society for Clinical Investigation, and the Amer- ican Society for Pharmacology and Experimental Therapeutics. Dr. Cooper is also a member of the Director's Advisory Committee of the National Institutes of Health, the Army Science Board, and the Advisory Council on Hazardous Substances Research and Training. KRISTINE GEBBIE is the administrator of the Oregon Health Division, a position she has held since 1978. She has taught nursing studies at St. Louis University and the University of California, Los Angeles, and is an adjunct associate professor of nursing at the Oregon Health Sciences University School of Nursing. She is presently a member of the Presi- dential Commission on the Human Immunodeficiency Virus Epidemic. Ms. Gebbie is past president of the Association of State and Territorial Health Officials and chairs the Oregon AIDS Task Force. She received a B.S. degree in nursing from St. Olaf College, Minnesota, and an M.N. in community mental health nursing from the University of California School of Nursing in Los Angeles. DONALD R. HOPKINS is a senior consultant to Global 2000 Inc. and the Task Force for Child Survival of the Carter Presidential Center in Atlanta, Georgia. From 1984 to 1987, he was deputy director of the

OCR for page 221
APPENDIX D 223 Centers for Disease Control; he served as assistant director for interna- tional health at CDC from 1978 to 1984. Dr. Hopkins taught tropical public health at the Harvard School of Public Health from 1974 to 1977 and directed the smallpox eradication program in Sierra Leone from 1967 to 1969. He has also authored an authoritative text on the history of smallpox, Princes and Peasants: Smallpox in History. Dr. Hopkins received his B.S. degree from Morehouse College, the M.D. degree from the University of Chicago, an M.P.H. from Harvard University, and an honorary D.Sc. from Morehouse College. He is a member of the Institute of Medicine. KENNETH PREWITT, a political scientist, came to the Rockefeller Foundation in 1985 from the presidency (1979-1985) of the Social Science Research Council. From 1965 to 1982 he was a faculty member of the University of Chicago, becoming chairman of its Department of Political Science in 1975 and the following year, director of the National Opinion Research Center. Dr. Prewitt has had extensive first-hand experience in Africa, first as a visiting lecturer (1965-1966) at the University of East Africa and Makarere, Uganda, and subsequently (1970-1973) as a Rocke- feller Foundation Visiting Research Fellow at the University of Nairobi in Kenya. Dr. Prewitt received his B.A. degree from Southern Methodist University, an M.A. degree from Washington University, and his Ph.D. from Stanford University. He is a director of (among other organizations) the Center for Advanced Study in the Behavioral Sciences at Washington University and the author or coauthor of a dozen books. He is also a member of the advisory bodies of several universities, foundations, and academic councils. Dr. Prewitt is a member of the American Academy of Arts and Sciences and the recipient of a Guggenheim fellowship. HOWARD M. TEMIN is American Cancer Society Professor of Viral Oncology, Harold P. Rusch Professor of Cancer Research, and Steen- bock Professor of Biological Sciences at the University of Wisconsin School of Medicine, Madison, where he has been since 1960. He has worked on retroviruses continuously since 1956, when he was a graduate student at the California Institute of Technology. In 1975 he received the Nobel Prize, together with David Baltimore and Renato Dulbecco, for some of this work. He is a member of the National Academy of Sciences and has served on the National Institutes of Health Virology Study Section and on the editorial board of several virology journals. He was also a member of the committee that wrote Confronting AIDS. PAUL VOLBERDING is associate professor of medicine at the Univer- sity of California, San Francisco, and chief of the Medical Oncology

OCR for page 221
224 APPENDIX D Division and the AIDS Program at San Francisco General Hospital. During the past several years he has served on a variety of local, national, and international AIDS committees. He was a member of the steering committee of the IOM/ NAS panel that wrote Confronting AIDS and is on the executive committee of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Dr. Volberding is actively involved in the provision of care to AIDS patients and undertakes clinical research in the treatment of HIV infection and Kaposi's sarcoma. He received an A.B. degree from the University of Chicago and an M.D. from the University of Minnesota.